PKM and chronic myelogenous leukemia, BCR-ABL1 positive: Pyruvate kinase (PKM2) and lactate dehydrogenase A (LDHA) play important roles in the initiation, maintenance, and progression of CML and AML in mice, and deletion of PKM2 or LDHA results in significantly prolonged disease latency (29).